Fidelity International’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $176M | Sell |
191,147
-6,374
| -3% | -$6.46M | 0.14% | 166 |
|
|
2025
Q4 | $212M | Buy |
197,521
+119,958
| +155% | +$115M | 0.16% | 160 |
|
|
2025
Q3 | $59.2M | Sell |
77,563
-77,329
| -50% | -$57.5M | 0.05% | 314 |
|
|
2025
Q2 | $121M | Sell |
154,892
-44,022
| -22% | -$34.2M | 0.1% | 203 |
|
|
2025
Q1 | $164M | Buy |
198,914
+25,134
| +14% | +$20.9M | 0.16% | 166 |
|
|
2024
Q4 | $134M | Sell |
173,780
-95,111
| -35% | -$78.8M | 0.13% | 185 |
|
|
2024
Q3 | $238M | Sell |
268,891
-11,833
| -4% | -$10.6M | 0.22% | 127 |
|
|
2024
Q2 | $254M | Buy |
280,724
+49,403
| +21% | +$39.5M | 0.25% | 107 |
|
|
2024
Q1 | $180M | Buy |
231,321
+20,327
| +10% | +$14.5M | 0.18% | 146 |
|
|
2023
Q4 | $123M | Sell |
210,994
-26,432
| -11% | -$15.4M | 0.13% | 201 |
|
|
2023
Q3 | $128M | Sell |
237,426
-3,230
| -1% | -$1.66M | 0.15% | 175 |
|
|
2023
Q2 | $113M | Buy |
240,656
+76,481
| +47% | +$32.1M | 0.13% | 182 |
|
|
2023
Q1 | $56.4M | Sell |
164,175
-24,157
| -13% | -$8.15M | 0.06% | 277 |
|
|
2022
Q4 | $68.9M | Buy |
188,332
+448
| +0.2% | +$159K | 0.08% | 245 |
|
|
2022
Q3 | $60.8M | Buy |
187,884
+56,614
| +43% | +$17.9M | 0.08% | 249 |
|
|
2022
Q2 | $42.6M | Sell |
131,270
-12,092
| -8% | -$3.63M | 0.05% | 298 |
|
|
2022
Q1 | $41.1M | Sell |
143,362
-102,835
| -42% | -$26.5M | 0.04% | 328 |
|
|
2021
Q4 | $68M | Buy |
246,197
+6,351
| +3% | +$1.61M | 0.07% | 251 |
|
|
2021
Q3 | $55.4M | Buy |
239,846
+9,372
| +4% | +$2.31M | 0.06% | 285 |
|
|
2021
Q2 | $52.9M | Sell |
230,474
-28,265
| -11% | -$5.68M | 0.06% | 300 |
|
|
2021
Q1 | $48.3M | Hold |
258,739
| – | – | 0.06% | 292 |
|
|
2020
Q4 | $43.7M | Buy |
258,739
+258,544
| +132,587% | +$38.6M | 0.05% | 305 |
|
|
2020
Q3 | $29K | Hold |
195
| – | – | ﹤0.01% | 711 |
|
|
2020
Q2 | $32K | Sell |
195
-5
| -3% | -$767 | ﹤0.01% | 702 |
|
|
2020
Q1 | $28K | Sell |
200
-89
| -31% | -$12.2K | ﹤0.01% | 676 |
|
|
2019
Q4 | $38K | Sell |
289
-199,469
| -100% | -$23.1M | ﹤0.01% | 711 |
|
|
2019
Q3 | $22.3M | Sell |
199,758
-86,386
| -30% | -$9.62M | 0.03% | 358 |
|
|
2019
Q2 | $31.7M | Sell |
286,144
-19,878
| -6% | -$2.34M | 0.05% | 313 |
|
|
2019
Q1 | $39.7M | Buy |
306,022
+113,584
| +59% | +$13.8M | 0.06% | 273 |
|
|
2018
Q4 | $22.3M | Sell |
192,438
-77,453
| -29% | -$8.65M | 0.04% | 336 |
|
|
2018
Q3 | $29M | Buy |
269,891
+37,522
| +16% | +$3.75M | 0.04% | 343 |
|
|
2018
Q2 | $19.8M | Sell |
232,369
-177,699
| -43% | -$14.6M | 0.03% | 392 |
|
|
2018
Q1 | $31.7M | Sell |
410,068
-113,399
| -22% | -$9.13M | 0.09% | 205 |
|
|
2017
Q4 | $44.2M | Sell |
523,467
-137,502
| -21% | -$11.7M | 0.12% | 172 |
|
|
2017
Q3 | $56.5M | Sell |
660,969
-31,081
| -4% | -$2.55M | 0.16% | 139 |
|
|
2017
Q2 | $57M | Sell |
692,050
-137,900
| -17% | -$11.3M | 0.16% | 141 |
|
|
2017
Q1 | $69.8M | Sell |
829,950
-41,144
| -5% | -$3.3M | 0.2% | 128 |
|
|
2016
Q4 | $64.1M | Sell |
871,094
-52,677
| -6% | -$3.92M | 0.19% | 127 |
|
|
2016
Q3 | $74.1M | Sell |
923,771
-17,382
| -2% | -$1.39M | 0.22% | 109 |
|
|
2016
Q2 | $74.1M | Sell |
941,153
-12,056
| -1% | -$908K | 0.24% | 102 |
|
|
2016
Q1 | $68.6M | Buy |
953,209
+623,513
| +189% | +$47.2M | 0.21% | 105 |
|
|
2015
Q4 | $27.8M | Sell |
329,696
-1,775,246
| -84% | -$147M | 0.08% | 218 |
|
|
2015
Q3 | $176M | Sell |
2,104,942
-2,003,234
| -49% | -$169M | 0.61% | 47 |
|
|
2015
Q2 | $343M | Sell |
4,108,176
-1,715,459
| -29% | -$131M | 1.09% | 19 |
|
|
2015
Q1 | $423M | Buy |
5,823,635
+559,651
| +11% | +$39.8M | 1.36% | 14 |
|
|
2014
Q4 | $363M | Buy |
5,263,984
+3,138,241
| +148% | +$212M | 1.25% | 14 |
|
|
2014
Q3 | $138M | Buy |
2,125,743
+713,918
| +51% | +$45.2M | 0.53% | 53 |
|
|
2014
Q2 | $87.8M | Buy |
+1,411,825
| New | +$84.2M | 0.33% | 81 |
|
Other funds holding LLY
VCM
VPM
Fidelity International's LLY Position: Q1 2026 in Review
Fidelity International reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $6.46M and leaving 191,147 shares worth $176M. The position accounts for 0.14% of the portfolio, ranked #166.
Fidelity International first reported a position in LLY in Q2 2014 and has held it in 48 quarters since. The position peaked at $423M in Q1 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Fidelity International held 191,147 shares of Eli Lilly worth $176M as of Q1 2026.
- Fidelity International sold 6,374 Eli Lilly shares in Q1 2026, an estimated $6.46M.
- Eli Lilly made up 0.14% of Fidelity International's portfolio in Q1 2026, its #166 holding.
- Fidelity International first reported a position in Eli Lilly in Q2 2014 and has held it in 48 quarters since.
- Fidelity International's Eli Lilly position peaked at $423M in Q1 2015.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.